Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review

Nasser M Alorfi, Alanood S Algarni Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi ArabiaCorrespondence: Nasser M Alorfi, Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia, Tel +966500644...

Full description

Bibliographic Details
Main Authors: Alorfi NM, Algarni AS
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Clinical Pharmacology: Advances and Applications
Subjects:
Online Access:https://www.dovepress.com/clinical-impact-of-semaglutide-a-glucagon-like-peptide-1-receptor-agon-peer-reviewed-fulltext-article-CPAA